Morepen Laboratories Share Price

Morepen Labs.

CMP as on 27-Oct-20 15:49

₹ 25.75
0.10 0.39%

Open

₹ 25.60

Turnover (lac)

₹ 190

Prev. Close

₹ 25.65

Day's Vol (shares)

₹ 7,36,853

Day's Range (₹)

₹ 25.35
₹ 26.15

CMP as on27-Oct-20 15:57

₹ 25.75
0.1 0.39%

Open

₹ 25.50

Turnover (lac)

₹ 76

Prev. Close

₹ 25.65

Day's Vol (shares)

₹ 1,07,936

Day's Range

₹ 25.30
₹ 26.10

Corporate Action

Go
Purpose AGM Date Announcement Date Book Closure Start Date Book Closure End Date
Board Meeting - 07-Oct-2020 - -
MOREPEN LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/10/2020 ,inter alia, to consider and approve proposal for raising of funds, through one or more modes including further public offer/ right issue/ preferential issue of equity shares/ warrants/ fully or partly convertible instruments to public, investors, including institutions, promoters, promoter group and/or other entities, subject to such regulatory/statutory and other approvals as may be required. Please find attached outcome of Board meeting held on 10th October, 2020 (As Per BSE Announcement Dated on 10.10.2020) Board to approval of members of the Company, considered and approved issue and allotment of up-to 16,85,00,000 (Sixteen Crore Eighty-Five Lakh) Fully Convertible Warrants (Warrants) to the entities belonging to Promoter Group of the Company, at a price of Rs. 25/-(Rupees Twenty-Five Only) per Warrant, aggregating up-to Rs. 421,25,00,000/-(Rupees Four Hundred Twenty-One Crore and Twenty-Five Lakh Only) carrying right by the Warrant holder to conve11 and subscribe 1 (One) Equity Share of Rs. 2/- (Rupees Two Only) each against each Warrant, at a price of Rs. 25/-(Rupees Twenty- Five Only) (including the warrant subscription price and the warrant exercise price) per share, on a preferential basis in accordance with SEBI (I CDR) Regulations, 2018 and other applicable laws. An Extraordinary General Meeting of the members of the Company will be held on Thursday, November 05, 2020, through Video Conferencing/ Other Audio Video Means, for seeking approval of the members for the said preferential issue. The requisite details as required under Regulation 30 of the SEBI Listing Regulations read with SEBI Circular No. CIR/CFD/CMD/4/2015 dated September 9, 2015.with respect to the preferential Issue of Warrants. Please find attached outcome of Board meeting held on 10th October, 2020 (As Per BSE Bulletin Dated on 10.10.2020)
Board Meeting - 24-Aug-2020 - -
MOREPEN LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/08/2020 ,inter alia, to consider and approve the Un-audited Financial Results of the Company for the Quarter ended 30th June, 2020. This is to inform you that the Board of Directors of the Company, in their meeting held on Monday, 31st August, 2020 (commenced at 12.00 Noon and concluded at 01.30 P.M.), have, inter-alia, considered and approved (1) The unaudited standalone and consolidated financial results of the Company for the quarter ended 30th June, 2020, pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended. A copy of the Results along-with the Limited Review Report of the Auditors of the Company for the quarter ended 30th June, 2020 is enclosed herewith. (2) Expansion of APIs (bulk drugs) manufacturing capacity. (As per BSE Announcement Dated on 31/8/2020)
Board Meeting - 15-Jun-2020 - -
MOREPEN LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/06/2020 ,inter alia, to consider and approve the Audited Financial Results of the Company for the Quarter and Financial Year ended 31st March, 2020. Please find attached outcome of board meeting held 22.06.2020 (As Per BSE Announcement dated on 22.06.2020)
Board Meeting - 07-Feb-2020 - -
MOREPEN LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2020 ,inter alia, to consider and approve the Un-Audited Financial Results For The Quarter Ended 31st December,2019 Please find attached outcome of Board Meeting held on Friday, 14th February, 2020 (As Per BSE Announcement dated on 14.02.2020)
Board Meeting - 06-Nov-2019 - -
MOREPEN LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2019 ,inter alia, to consider and approve the Un-audited Financial Results of the Company for the quarter and half-year ended 30th September, 2019. Please find attached outcome of Board Meeting held on 13th November, 2019 The Board of Directors of the Company, in their meeting held on Wednesday, 13th November, 2019 (commenced at 12.00 Noon and concluded at 01.45 P.M.), have, inter-alia, considered and approved the Un-audited Standalone and Consolidated Financial Results of the Company for the Quarter and Half-Year ended 30th September, 2019, pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended. (As Per BSE Announcement Dated 13.11.2019)